Market openNon-fractional

BioLife Solutions/BLFS

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About BioLife Solutions

BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.

Ticker

BLFS

Sector

Healthcare

Trading on

NASDAQ

Industry

Life Sciences Tools and Services

Headquarters

Bothell, United States

Employees

-

BLFS Metrics

BasicAdvanced
$923M
Market cap
-
P/E ratio
-$1.42
EPS
1.69
Beta
-
Dividend rate
$923M
1.69
2.889
1.652
8.86
8.86
-33.92%
-8.04%
-18.20%
6.466
2.73
2.73
-40.311
-15.89%
-58.45%
37.54%
28.90%

What the Analysts think about BLFS

Analyst Ratings

Majority rating from 9 analysts.
Buy

BLFS Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-32.17% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$32M
-3.06%
Net income
-$10M
-23.31%
Profit margin
-32.17%
-20.90%

BLFS Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 17.86%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.23
-$0.67
-$0.30
-$0.23
-
Expected
-$0.20
-$0.38
-$0.34
-$0.28
-$0.14
Surprise
15.00%
78.67%
-12.20%
-17.86%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market openNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for BioLife Solutions stock?

BioLife Solutions (BLFS) has a market cap of $923M as of July 05, 2024.

What is the P/E ratio for BioLife Solutions stock?

The price to earnings (P/E) ratio for BioLife Solutions (BLFS) stock is 0 as of July 05, 2024.

Does BioLife Solutions stock pay dividends?

No, BioLife Solutions (BLFS) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next BioLife Solutions dividend payment date?

BioLife Solutions (BLFS) stock does not pay dividends to its shareholders.

What is the beta indicator for BioLife Solutions?

BioLife Solutions (BLFS) has a beta rating of 1.69. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell BioLife Solutions stock

Buy or sell BioLife Solutions stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing